Your cart

Your cart is empty


Explore our range of products

15% off

Canongate Books Paperback English

Sick Money

Sky-high Prices and Dirty Tricks: Inside the Global Pharmaceutical Industry

By Billy Kenber

Regular price £10.99 £9.34 Save 15%
Unit price
per
15% off

Canongate Books Paperback English

Sick Money

Sky-high Prices and Dirty Tricks: Inside the Global Pharmaceutical Industry

By Billy Kenber

Regular price £10.99 £9.34 Save 15%
Unit price
per
 
Dispatched today with Tracked Delivery - free when you spend over £15
Delivery expected between Wednesday, 1st July and Thursday, 2nd July
(0 in cart)
Apple Pay
Google Pay
Maestro
Mastercard
PayPal
Shop Pay
Visa

You may also like

  • THE PHARMACEUTICAL INDUSTRY IS BROKEN From the American hedge fund manager who drastically hiked the price of an AIDS pill to the children's cancer drugs left intentionally to expire in a Spanish warehouse, the signs of this dysfunction are all around. A system built to drive innovation and improve patient care has been distorted to maximise profits. In Sick Money, the investigative journalist who exposed a billion-pound British price-hiking scandal goes inside the global battle over high drug prices. From secret deals to patients forced to turn to the black market, Billy Kenber reveals how medicines have become nothing more than financial assets. He offers a diagnosis of an industry in crisis - and a prescription for how it could be fixed.
THE PHARMACEUTICAL INDUSTRY IS BROKEN From the American hedge fund manager who drastically hiked the price of an AIDS pill to the children's cancer drugs left intentionally to expire in a Spanish warehouse, the signs of this dysfunction are all around. A system built to drive innovation and improve patient care has been distorted to maximise profits. In Sick Money, the investigative journalist who exposed a billion-pound British price-hiking scandal goes inside the global battle over high drug prices. From secret deals to patients forced to turn to the black market, Billy Kenber reveals how medicines have become nothing more than financial assets. He offers a diagnosis of an industry in crisis - and a prescription for how it could be fixed.